Drug Trial Radar · NCT05545111
Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With Schizophrenia
Last checked: Nov 20, 2026Latest source record: Jul 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
210
Actual
Start
Oct 4, 2022
Primary completion
Jul 10, 2024
Study completion Jul 10, 2024
Sponsor
- Lead sponsor
- Neurocrine BiosciencesNeurocrine Biosciences (NBIX)
- Sponsor type
- Industry
- First posted
- Sep 19, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 2, multicenter, randomized, double-blind, placebo-controlled, multi-arm, multi-stage inpatient study designed to assess the efficacy, safety, tolerability, and pharmacokinetics (PK) of NBI-1117568 compared with placebo in adult subjects with a primary diagnosis of schizophrenia, who are experiencing an acute exacerbation or relapse of symptoms.
Conditions
- Schizophrenia
Interventions
NBI-1117568Drug
Active treatment with orally administered NBI-1117568
PlaceboDrug
Placebo matching NBI-1117568
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in total Positive and Negative Syndrome Scale (PANSS) score at Week 6Time frame: Baseline and Week 6
Locations
15 sites in 1 country. Site status is shown where the registry gives one.
Neurocrine Clinical Site
Little Rock, Arkansas
Neurocrine Clinical Site
Rogers, Arkansas
Neurocrine Clinical Site
Lemon Grove, California
Neurocrine Clinical Site
Pico Rivera, California
Neurocrine Clinical Site
San Diego, California
Neurocrine Clinical Site
Torrance, California
Neurocrine Clinical Site
Miami Lakes, Florida
Neurocrine Clinical Site
Oakland Park, Florida
Neurocrine Clinical Site
Gaithersburg, Maryland
Neurocrine Clinical site
St Louis, Missouri
Neurocrine Clinical Site
Berlin, New Jersey
Neurocrine Clinical Site
North Canton, Ohio
Neurocrine Clinical Site
Austin, Texas
Neurocrine Clinical Site
DeSoto, Texas
Neurocrine Clinical Site
Richardson, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.